HIKMA Pharmaceuticals PLC — Director's Dealing 2019

Mar 13, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7823S

Hikma Pharmaceuticals Plc

13 March 2019

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mazen Darwazah

2

Reason for the notification

a)

Position/status

Executive Vice Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

Market purchase of 20,000 Ordinary Shares by Capital Investment & Brokerage / Jordan Ltd. Co for and on behalf of Mazen Darwazah.

c)

Price(s) and volume(s)

Price(s): £15.8198

Volume(s): 20,000

d)

Aggregated information

-       Volume

-       Price

20,000

£316,396.00

e)

Date of the transaction

13 March 2019

f)

Place of the transaction

London Stock Exchange (XLON)

Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760

13 March 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBXGDXISBBGCX